Amgen is one of the world’s leading biotechnology companies.
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world’s largest independent biotechnology companies, Amgen was established in Thousand Oaks, California in 1980. Amgen’s Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
In 2018, the company’s largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA. Amgen sponsors the Tour of California.
The tech sector continues to take the markets ahead as indices hit new highs. The U.S. and China have resumed the phase one of the trade talks as the two giant economies plan to come to common grounds with their trade settlements.
The shares of Salesforce.com, Amgen and Honeywell will replace those of Exxon Mobil, Pfizer and Raytheon Technologies respectively in Dow Jones 30 stock listed. The implementation will become effective before the start of trading on August 31.
Amgen reported Q2 earnings that beat Wall Street estimates, but AMGN stock fell over 1% in after-hours trading. The company reported non-GAAP earnings per share of $4.25 for the second quarter.